About   Help   FAQ
Phenotypes associated with this allele
Allele Symbol
Allele Name
Allele ID
Trp63tm2Brd
targeted mutation 2, Allan Bradley
MGI:1934580
Summary 7 genotypes
Jump to Allelic Composition Genetic Background Genotype ID
hm1
Trp63tm2Brd/Trp63tm2Brd B6.129S7-Trp63tm2Brd/J MGI:5140826
hm2
Trp63tm2Brd/Trp63tm2Brd involves: 129S7/SvEvBrd MGI:3773057
hm3
Trp63tm2Brd/Trp63tm2Brd involves: 129S7/SvEvBrd * C57BL/6J MGI:3511141
ht4
Trp63tm2Brd/Trp63+ B6.129S7-Trp63tm2Brd/J MGI:5140827
ht5
Trp63tm2Brd/Trp63+ involves: 129S7/SvEvBrd MGI:3798055
cn6
Tg(KRT5-cre/PGR)1Der/0
Trp63tm2Brd/Trp63tm3.1Brd
involves: 129S7/SvEvBrd * FVB * ICR MGI:3798054
cx7
Kdf1shd/Kdf1shd
Trp63tm2Brd/Trp63+
involves: 129S7/SvEvBrd * C3HeB/FeJ * C57BL/6J MGI:5559506


Genotype
MGI:5140826
hm1
Allelic
Composition
Trp63tm2Brd/Trp63tm2Brd
Genetic
Background
B6.129S7-Trp63tm2Brd/J
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Trp63tm2Brd mutation (1 available); any Trp63 mutation (60 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
taste/olfaction
• at P0, failure of horizontal basal cells differentiation
• at P0, axon bundles are not covered over by the arching processes of basal cells
• cells with olfactory gland morphology are clustered in the olfactory epithelium superficial to the basal lamina
• at P0, failure of horizontal basal cells differentiation
• at P0 the extension of the ducts of the olfactory glands into the lamina propria is stunted

endocrine/exocrine glands
• at P0 the extension of the ducts of the olfactory glands into the lamina propria is stunted

respiratory system
• at P0, failure of horizontal basal cells differentiation
• at P0, axon bundles are not covered over by the arching processes of basal cells
• cells with olfactory gland morphology are clustered in the olfactory epithelium superficial to the basal lamina
• at P0, failure of horizontal basal cells differentiation

craniofacial
• at P0, failure of horizontal basal cells differentiation
• at P0, axon bundles are not covered over by the arching processes of basal cells
• cells with olfactory gland morphology are clustered in the olfactory epithelium superficial to the basal lamina
• at P0, failure of horizontal basal cells differentiation

growth/size/body
• at P0, failure of horizontal basal cells differentiation
• at P0, axon bundles are not covered over by the arching processes of basal cells
• cells with olfactory gland morphology are clustered in the olfactory epithelium superficial to the basal lamina
• at P0, failure of horizontal basal cells differentiation




Genotype
MGI:3773057
hm2
Allelic
Composition
Trp63tm2Brd/Trp63tm2Brd
Genetic
Background
involves: 129S7/SvEvBrd
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Trp63tm2Brd mutation (1 available); any Trp63 mutation (60 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
limbs/digits/tail

cellular
• mice exhibit an increase in cellular senescence

craniofacial

muscle
N
• proximal thigh and cloacal/perineal muscles are fully formed

embryo

integument
• mice exhibit stratified epidermal layer and arrested epidermal morphogenesis




Genotype
MGI:3511141
hm3
Allelic
Composition
Trp63tm2Brd/Trp63tm2Brd
Genetic
Background
involves: 129S7/SvEvBrd * C57BL/6J
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Trp63tm2Brd mutation (1 available); any Trp63 mutation (60 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
mortality/aging
• death occurs within several hours of birth

embryo
• at E11.5, both the mesenchyme and epithelium of the ventral UGS develop abnormally
• at E11.5, apoptosis is significantly increased in the ventral UGS epithelium, as determined by TUNEL assay and cleaved caspase-3 expression
• at E11.5, a reduction in cell proliferation is observed in the UGS mesenchyme relative to wild-type controls, as shown by BrdU staining
• small and misshapen at E11.5
• at E18.5, homozygotes with bladder exstrophy exhibit umbilical hernia

limbs/digits/tail
• small and misshapen at E11.5
• truncated
• all are missing
• usually truncated, thinner than normal and deformed
• sometimes absent

skeleton
• all are missing
• usually truncated, thinner than normal and deformed
• sometimes absent
• pelvic girdle usually present but lacking ossification centers
• at E18.5, homozygotes with bladder exstrophy exhibit absence of pubic symphysis at the midline (i.e. separation of the pubic bones)

craniofacial
• abnormal faces

homeostasis/metabolism
• water loss occurs 30X more rapidly than in controls, a skin permeability problem

integument
• skin at birth totally lacks hair follicles
• reduced to a single layer of flattened cells
• epithelium of tongue and oral cavity is similar to the epidermis
• epidermal development apparently stops around E9.5
• water loss occurs 30X more rapidly than in controls, a skin permeability problem

renal/urinary system
• at E18.5, 4 of 12 homozygotes display bladder exstrophy with ventral bladder- and abdominal-wall defects (with and without membrane cover)
• the remaining 8 embryos develop dilated bladders with both thin lamina propria and thin muscle layers
• at E18.5, the lamina propria is either greatly reduced or absent
• at E18.5, 8 of 12 homozygotes exhibit dilated bladders with thin muscle layers
• at E14.5, premature smooth-muscle differentiation is observed relative to wild-type bladders
• at E18.5, little or no smooth muscle is detected ventrally, while a thin layer of smooth muscle is retained dorsally
• dorsal smooth muscle appears disorganized and non-stratified, unlike in wild-type bladders
• at E18.5, an abnormal bladder epithelium is observed along the dorso-ventral axis, with the dorsal epithelium consisting mainly of simple cuboidal cells and the ventral epithelium consisting primarily of simple squamous cells
• the ventral urothelium is neither committed to stratification nor differentiated, whereas the dorsal urothelium is both committed and differentiated
• at E11.5, a reduction in cell proliferation is observed in the ventral bladder epithelium and in adjacent mesenchyme relative to wild-type controls, as shown by BrdU staining
• at E12.5, an increase in ventral bladder epithelial apoptosis is associated with a transient upregulation of p53 and p73 expression
• at E12.5 and E13.5, developing bladders exhibit increased mitochondrial apoptotic activity relative to wild-type controls
• at E18.5, the bladder epithelium fails to differentiate into stratified transitional urothelium and remains as a single layer, unlike in wild-type controls
• at E18.5, 8 of 12 homozygotes develop dilated bladders with both thin lamina propria and thin muscle layers

reproductive system
• at E18.5, homozygotes with bladder exstrophy exhibit absence of external genitalia at the midline (i.e. bifid genitalia)
• separation of external genitalia is already noted at E11.5

growth/size/body
• abnormal faces
• at E18.5, 4 of 12 homozygotes display ventral abdominal wall defects
• at E18.5, 4 of 12 homozygotes display bladder exstrophy with ventral bladder- and abdominal-wall defects (with and without membrane cover)
• the remaining 8 embryos develop dilated bladders with both thin lamina propria and thin muscle layers
• at E18.5, the lamina propria is either greatly reduced or absent

digestive/alimentary system
• at E18.5, homozygotes with bladder exstrophy exhibit ventral translocation of the anus

muscle
• at E18.5, 8 of 12 homozygotes exhibit dilated bladders with thin muscle layers
• at E14.5, premature smooth-muscle differentiation is observed relative to wild-type bladders
• at E18.5, little or no smooth muscle is detected ventrally, while a thin layer of smooth muscle is retained dorsally
• dorsal smooth muscle appears disorganized and non-stratified, unlike in wild-type bladders

cellular
• at E11.5, apoptosis is significantly increased in the ventral UGS epithelium, in skin overlying the urogenital tubercles, and in oral-cavity epithelium, as determined by TUNEL assay and/or cleaved caspase-3 expression
• at E12.5 and E13.5, developing bladders exhibit increased mitochondrial apoptotic activity, as revealed by increased expression of the mitochondrial apoptotic mediators




Genotype
MGI:5140827
ht4
Allelic
Composition
Trp63tm2Brd/Trp63+
Genetic
Background
B6.129S7-Trp63tm2Brd/J
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Trp63tm2Brd mutation (1 available); any Trp63 mutation (60 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
taste/olfaction
• at P0, fewer horizontal basal cells are present

respiratory system
• at P0, fewer horizontal basal cells are present

craniofacial
• at P0, fewer horizontal basal cells are present

growth/size/body
• at P0, fewer horizontal basal cells are present




Genotype
MGI:3798055
ht5
Allelic
Composition
Trp63tm2Brd/Trp63+
Genetic
Background
involves: 129S7/SvEvBrd
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Trp63tm2Brd mutation (1 available); any Trp63 mutation (60 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
mortality/aging
• median life span is 95 weeks compared to 121 weeks for wild-type mice
• longevity is decreased 21.5% compared to wild-type mice
• mice are euthanized due to age-related health issues (skin lesions or infections, weakness, palpable lymph nodes, enlarged abdomen, hemorrhage, rectal prolapse and aberrant circling behavior) earlier than wild-type mice

immune system
• 19% of of euthanized mice exhibit palpable lymph nodes
• mice exhibit chronic nephritis
• mice exhibit vaginal cervicitis
• mice develop chronic infections if the skin, subcutaneous tissues, oropharynx and genitourinary tract

digestive/alimentary system
• mice exhibit lesions in the epithelium of the tongue
• mice exhibit acanthosis of the tongue epithelia
• mice exhibit lesions in the epithelium of the rectum
• 6% of euthanized mice exhibit rectal prolapse

cardiovascular system
• 12% of euthanized mice exhibit visible signs of hemorrhage

reproductive system
• mice exhibit vaginal cervicitis
• mice exhibit lesions in the epithelium of the cervix

renal/urinary system
• mice exhibit chronic nephritis

growth/size/body
• mice exhibit lesions in the epithelium of the tongue
• mice exhibit acanthosis of the tongue epithelia
• 14% of euthanized mice exhibit enlarged abdomen

behavior/neurological
• 35% of euthanized mice exhibit extreme weakness
• 2% of euthanized mice exhibit aberrant circling

vision/eye
• mice exhibit lesions in the epithelium of the cornea of the eye
• mice exhibit corneal granulation

craniofacial
• mice exhibit lesions in the epithelium of the tongue
• mice exhibit acanthosis of the tongue epithelia

integument
• mice exhibit moderate alopecia
• mice exhibit acanthosis of the tongue epithelia
• 52% of euthanized mice exhibit skin lesions or infections mice exhibit hyperplastic epithelila and progressive skin lesions
• mice exhibit ulcerations with severe abscesses in the dermis that often contain bacterial inclusions




Genotype
MGI:3798054
cn6
Allelic
Composition
Tg(KRT5-cre/PGR)1Der/0
Trp63tm2Brd/Trp63tm3.1Brd
Genetic
Background
involves: 129S7/SvEvBrd * FVB * ICR
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Tg(KRT5-cre/PGR)1Der mutation (0 available)
Trp63tm2Brd mutation (1 available); any Trp63 mutation (60 available)
Trp63tm3.1Brd mutation (0 available); any Trp63 mutation (60 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
cellular
• following treatment with mifepristonein in utero, mice exhibit an increase in cellular senescence

craniofacial
• at E17.5 following treatment with mifepristonein in utero

limbs/digits/tail
• at E17.5 following treatment with mifepristonein in utero

growth/size/body
• following treatment with mifepristonein at 8 months of age

skeleton
• following treatment with mifepristonein at 8 months of age, mice exhibit lordokyphosis that increases with severity as mice age

integument
• following treatment with mifepristonein at 8 months of age, mice exhibit severe alopecia
• at E17.5 following treatment with mifepristonein in utero or at 8 months of age
• following treatment with mifepristonein utero, mice exhibit stratified epidermal layer and arrested epidermal morphogenesis




Genotype
MGI:5559506
cx7
Allelic
Composition
Kdf1shd/Kdf1shd
Trp63tm2Brd/Trp63+
Genetic
Background
involves: 129S7/SvEvBrd * C3HeB/FeJ * C57BL/6J
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Kdf1shd mutation (0 available); any Kdf1 mutation (17 available)
Trp63tm2Brd mutation (1 available); any Trp63 mutation (60 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
integument
N
• epidermal barrier formation, increased basal keratinocyte proliferation, lateral epidermis thickness and impaired keratinocyte differentiation defects observed in 1810019J16Rikshd homozygotes are rescued

limbs/digits/tail
N
• limb protrusion defects and tail-hindlimb fusion observed in 1810019J16Rikshd homozygotes homozygotes is rescued





Contributing Projects:
Mouse Genome Database (MGD), Gene Expression Database (GXD), Mouse Models of Human Cancer database (MMHCdb) (formerly Mouse Tumor Biology (MTB)), Gene Ontology (GO)
Citing These Resources
Funding Information
Warranty Disclaimer, Privacy Notice, Licensing, & Copyright
Send questions and comments to User Support.
last database update
12/10/2024
MGI 6.24
The Jackson Laboratory